Esteller M - Search Results

1

Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.

Amatu A, Sartore-Bianchi A, Moutinho C, Belotti A, Bencardino K, Chirico G, Cassingena A, Rusconi F, Esposito A, Nichelatti M, Esteller M, Siena S. Amatu A, et al. Among authors: esteller m. Clin Cancer Res. 2013 Apr 15;19(8):2265-72. doi: 10.1158/1078-0432.CCR-12-3518. Epub 2013 Feb 19. Clin Cancer Res. 2013. PMID: 23422094 Clinical Trial.

2

Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 1998 Oct 15;58(20):4515-8. Cancer Res. 1998. PMID: 9788592

3

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 1999 Jan 1;59(1):67-70. Cancer Res. 1999. PMID: 9892187

4

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 1999 Feb 15;59(4):793-7. Cancer Res. 1999. PMID: 10029064

5

Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.

Sanchez-Cespedes M, Esteller M, Hibi K, Cope FO, Westra WH, Piantadosi S, Herman JG, Jen J, Sidransky D. Sanchez-Cespedes M, et al. Among authors: esteller m. Clin Cancer Res. 1999 Sep;5(9):2450-4. Clin Cancer Res. 1999. PMID: 10499618 Clinical Trial.

6

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.

Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2000 May 1;60(9):2368-71. Cancer Res. 2000. PMID: 10811111

7

Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2000 Aug 15;60(16):4366-71. Cancer Res. 2000. PMID: 10969779

8

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2001 Apr 1;61(7):2816-21. Cancer Res. 2001. PMID: 11306450

9

A gene hypermethylation profile of human cancer.

Esteller M, Corn PG, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2001 Apr 15;61(8):3225-9. Cancer Res. 2001. PMID: 11309270

10

Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.

Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2001 Jun 15;61(12):4689-92. Cancer Res. 2001. PMID: 11406538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters